Stacy Ann Coen - 08 Sep 2023 Form 4 Insider Report for ImmunoGen, Inc.

Role
SVP & CHIEF BUSINESS OFFICER
Signature
/s/ Renee Lentini, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
08 Sep 2023
Net transactions value
+$199,986
Form type
4
Filing time
11 Sep 2023, 16:08:50 UTC
Previous filing
11 Aug 2023
Next filing
17 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMGN Common Stock Options Exercise $199,986 +26,006 +237% $7.69 36,966 08 Sep 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMGN Stock Option (Right to Buy) Options Exercise $0 -26,006 -14% $0.000000 159,010 08 Sep 2023 Common Stock 26,006 $7.69 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercisable as to 25% on the first year anniversary of the grant and 6.25% quarterly for the subsequent three years.